Retham Technologies

Manufacturing · Wisconsin, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

1225 Discovery Pkwy, Wauwatosa, Wisconsi...

Revenue

<$5 Million

Industry

Manufacturing Business Services Research & Development Medical Devices & Equipment
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Retham Technologies

Retham Technologies is focused on revolutionizing the diagnosis and management of Heparin-induced Thrombocytopenia (HIT) through the development of a simple in vitro diagnostic (IVD) test. Established in 2017, the company aims to provide rapid and accurate HIT testing to improve patient outcomes and reduce healthcare costs. Their innovative assay is designed to facilitate timely and appropriate therapy for HIT-suspected patients, addressing the challenges of current diagnostic methods. Retham Technologies targets healthcare providers and hospitals that require efficient and reliable HIT diagnostic solutions.Explore more
Retham Technologies's Social MediaPopular SearchesRetham Technologies LLCRetham TechnologiesRethamtechnologies.comSIC Code 38,384NAICS Code 33,339Show more

Retham Technologies Org Chart

PhoneEmail
AP
United States flag for contact location.

Chief Science Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
CJ
United States flag for contact location.

Vice President, Research & Innovation

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Retham Technologies your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Retham Technologies

Compare insights from companies similar to Retham Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Retham Technologies

<$5M
1-10
Private
-
-
AP
Anand PadmanabhanChief Science Officer
$6.6M
11-50
Private
-
2004
$5.7M
11-50
Private
-
2004
N/A
<$5M
11-50
Private
-
2013
Robert Granier, President & Chief Executive Officer at General Fluidics
Robert GranierPresident & CEO
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
1998
<$5M
1-10
Public
-
2013
RJ
Richard JohnsonChief Financial Officer
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Retham Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Retham Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Retham Technologies.

Retham Technologies Tech Stack

A closer look at the technologies used by Retham Technologies

Top Manufacturing Companies

Frequently Asked Questions Regarding Retham Technologies

What is Retham Technologies's official website?
Retham Technologies's official website is www.rethamtechnologies.com
What is Retham Technologies's Revenue?
Retham Technologies's revenue is <$5 Million
What is Retham Technologies's SIC code?
Retham Technologies's SIC: 38,384
What is Retham Technologies's NAICS code?
Retham Technologies's NAICS: 33,339
How many employees does Retham Technologies have?
Retham Technologies has 1-10 employees
What industry does Retham Technologies belong to?
Retham Technologies is in the industry of: Manufacturing, Business Services, Research & Development
What is Retham Technologies competition?
Retham Technologies top competitors include: First Diagnostic, StatChem, General Fluidics, Global WholeHealth Partners
What technology does Retham Technologies use?
Some of the popular technologies that Retham Technologies uses are: Sentry, Microsoft 365, WixStores, F5 BIG-IP Platform
What does Retham Technologies do?

Retham Technologies is focused on revolutionizing the diagnosis and management of Heparin-induced Thrombocytopenia (HIT) through the development of a simple in vitro diagnostic (IVD) test. Established in 2017, the company aims to provide rapid and accurate HIT testing to improve patient outcomes and reduce healthcare costs. Their innovative assay i... s designed to facilitate timely and appropriate therapy for HIT-suspected patients, addressing the challenges of current diagnostic methods. Retham Technologies targets healthcare providers and hospitals that require efficient and reliable HIT diagnostic solutions.Read More

What are Retham Technologies social media links?
Retham Technologies Linkedin page
Is Retham Technologies a public company?
Retham Technologies is private company therefore does not currently have an official ticker symbol
See more information about Retham Technologies

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.